Provided by Tiger Trade Technology Pte. Ltd.

FOSUN PHARMA

18.470
+0.6003.36%
Volume:5.10M
Turnover:93.69M
Market Cap:48.91B
PE:12.45
High:18.610
Open:17.880
Low:17.640
Close:17.870
52wk High:26.110
52wk Low:14.505
Shares:2.65B
HK Float Shares:530.00M
Volume Ratio:2.72
T/O Rate:0.96%
Dividend:0.46
Dividend Rate:2.47%
EPS(LYR):1.484
ROE:6.95%
ROA:1.40%
PB:0.86
PE(LYR):12.45
PS:0.98

Loading ...

Fosun Pharma Subsidiary Passes GMP Compliance Inspection

Stock News
·
Jun 17

Fosun Pharma Announces Final Dividend of RMB 0.39 Per Share for Payment on August 14

Stock News
·
Jun 16

Fosun Pharma Secures Shareholder Support for All AGM Proposals; Announces RMB0.39 Final Dividend

Bulletin Express
·
Jun 16

Fosun Pharma Unit's Luvometinib Gets China Nod for Langerhans Cell Histiocytosis Drug Indication

MT Newswires Live
·
Jun 16

Fosun Pharma Showcases Strategy at Abu Dhabi Forum, Highlighting Innovation and Collaboration as Key to China-UAE Healthcare Partnership

Deep News
·
Jun 15

Fosun Pharma secures NMPA nod for Luvometinib’s pediatric LCH indication, lifting rare-tumor portfolio

Bulletin Express
·
Jun 15

Shanghai Fosun Pharma - Drug Registration Application for Additional Indication of Luvometinib Tablets Approved by Nmpa

THOMSON REUTERS
·
Jun 15

Fosun Pharma's Shareholder Meeting Hints at Major Moves: Billions in Guarantees and Dual A/H Share Buybacks Revealed

Deep News
·
Jun 13

Sinopharm Group Stock Falls 1.6% in Hong Kong

Dow Jones
·
Jun 11

FOSUN INTL's "Strongest Valuation Anchor" Solidifies as Innovative Drug R&D and Commercialization Accelerates

Stock News
·
Jun 03

Subsidiary of FOSUN PHARMA Gains Approval for Pertuzumab Injection

Stock News
·
May 29

FOSUN PHARMA Invests Over 400 Million Yuan in Nucleic Acid Drug Firm

Deep News
·
May 27

Sinopharm Group Stock Falls 1.7% in Hong Kong

Dow Jones
·
May 27

Fosun Pharmaceutical to Invest 414 Million Yuan in Xingyao Kunze's Series B Funding Round

MT Newswires Live
·
May 27

Fosun Pharma Gets Registration Nod for Infection Drug in China

MT Newswires Live
·
May 21

Fosun Pharma receives NMPA clearance for Yaopharma-developed Levofloxacin Injection

Bulletin Express
·
May 21

FOSUN PHARMA Subsidiary Gains Approval for Levofloxacin Injection

Stock News
·
May 21

Shanghai Fosun Pharma - Drug Registration Application for Levofloxacin Injection Approved by China's Nmpa

THOMSON REUTERS
·
May 21

FOSUN PHARMA Subsidiary's HLX3902 Injection Approved for Clinical Trials in Australia

Stock News
·
May 21

Sinopharm Group Stock Sheds 1.2% in Hong Kong

Dow Jones
·
May 21